$CLRO
CLEARONE INC Stock $clro

$clro Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000175392624001441 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$2.504M	$2.304M	$5.483M
YoY Change	-48.78%	-57.98%	-25.65%
Cost Of Revenue	$1.892M	$2.324M	$3.635M
YoY Change	-42.19%	-36.07%	-20.42%
Gross Profit	$612.0K	-$20.00K	$1.848M
YoY Change	-62.13%	-101.08%	-34.16%
Gross Profit Margin	24.44%	-0.87%	33.7%
Selling, General & Admin	$2.018M	$2.036M	$2.330M
YoY Change	-8.94%	-12.62%	-28.94%
% of Gross Profit	329.74%		126.08%
Research & Development	$782.0K	$868.0K	$873.0K
YoY Change	-12.04%	-0.57%	-25.83%
% of Gross Profit	127.78%		47.24%
Depreciation & Amortization	$104.0K	$106.0K	$228.0K
YoY Change	-60.0%	-53.51%	-71.46%
% of Gross Profit	16.99%		12.34%
Operating Expenses	$2.800M	$2.904M	$3.203M
YoY Change	-9.82%	-9.33%	-28.12%
Operating Profit	-$2.188M	-$2.924M	-$1.355M
YoY Change	46.94%	115.79%	-17.83%
Interest Expense	-$29.00K	$0.00	-$91.00K
YoY Change	-133.72%	-100.0%	-196.81%
% of Operating Profit
Other Income/Expense, Net	$113.0K	$119.0K	$437.0K
YoY Change	-53.5%	-72.77%	-70.96%
Pretax Income	-$2.046M	-$2.805M	-$1.009M
YoY Change	53.6%	178.0%	323.95%
Income Tax	$16.00K	$15.00K	$10.00K
% Of Pretax Income
Net Earnings	-$2.062M	-$2.820M	-$1.019M
YoY Change	52.63%	176.74%	296.5%
Net Earnings / Revenue	-82.35%	-122.4%	-18.58%
Basic Earnings Per Share	-$0.09	-$0.12	-$0.04
Diluted Earnings Per Share	-$0.09	-$0.12	-$0.04
COMMON SHARES
Basic Shares Outstanding	23.97M shares	23.97M shares	23.96M shares
Diluted Shares Outstanding	23.97M shares	23.97M shares	23.96M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.043M	$4.923M	$21.49M
YoY Change	-84.77%	-77.1%	1686.7%
Cash & Equivalents	$1.685M	$2.450M	$15.09M
Short-Term Investments	$1.358M	$2.473M	$6.408M
Other Short-Term Assets	$4.054M	$3.855M	$4.273M
YoY Change	7.25%	-9.78%	46.14%
Inventory	$14.27M	$14.60M	$7.547M
Prepaid Expenses
Receivables	$1.868M	$2.574M	$4.232M
Other Receivables	$27.00K	$27.00K	$6.381M
Total Short-Term Assets	$23.04M	$25.36M	$43.93M
YoY Change	-45.26%	-42.27%	71.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$518.0K	$552.0K	$1.785M
YoY Change	-12.2%	-69.08%	190.72%
Goodwill
YoY Change
Intangibles	$1.567M	$1.582M	$1.903M
YoY Change	-12.65%	-16.87%	-92.17%
Long-Term Investments	$222.0K	$621.0K	$586.0K
YoY Change	-61.72%	5.97%
Other Assets	$78.00K	$108.0K	$3.475M
YoY Change	-30.36%	-96.89%	-24.32%
Total Long-Term Assets	$5.340M	$5.439M	$7.749M
YoY Change	-24.04%	-29.81%	-77.02%
TOTAL ASSETS
Total Short-Term Assets	$23.04M	$25.36M	$43.93M
Total Long-Term Assets	$5.340M	$5.439M	$7.749M
Total Assets	$28.38M	$30.80M	$51.68M
YoY Change	-42.22%	-40.41%	-12.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.248M	$1.901M	$2.435M
YoY Change	-29.05%	-21.93%	18.95%
Accrued Expenses	$2.057M	$1.726M	$2.587M
YoY Change	-12.09%	-33.28%	0.66%
Deferred Revenue	$22.00K	$23.00K	$52.00K
YoY Change	-42.11%	-55.77%	20.93%
Short-Term Debt	$0.00	$0.00	$1.380M
YoY Change	-100.0%	-100.0%	70.37%
Long-Term Debt Due			$1.380M
YoY Change			70.37%
Total Short-Term Liabilities	$3.327M	$3.650M	$6.454M
YoY Change	-37.71%	-43.45%	17.99%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$1.079M	$1.079M	$1.856M
YoY Change	7.04%	-41.86%	183.36%
Total Long-Term Liabilities	$1.079M	$1.079M	$1.856M
YoY Change	7.04%	-41.86%	0.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.327M	$3.650M	$6.454M
Total Long-Term Liabilities	$1.079M	$1.079M	$1.856M
Total Liabilities	$4.878M	$5.244M	$8.310M
YoY Change	-31.33%	-36.9%	3.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.856M	-$5.794M	-$2.367M
YoY Change	111.3%	144.78%	-89.84%
Common Stock	$31.66M	$31.64M	$46.00M
YoY Change	-31.22%	-31.22%	-38.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.50M	$25.55M	$43.37M
YoY Change
Total Liabilities & Shareholders Equity	$28.38M	$30.80M	$51.68M
YoY Change	-42.22%	-40.41%	-12.93%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$2.062M	-$2.820M	-$1.019M
YoY Change	52.63%	176.74%	296.5%
Depreciation, Depletion And Amortization	$104.0K	$106.0K	$228.0K
YoY Change	-60.0%	-53.51%	-71.46%
Cash From Operating Activities	-$1.853M	-$3.155M	-$7.401M
YoY Change	4.1%	-57.37%	348.82%
INVESTING ACTIVITIES
Capital Expenditures	$55.00K	$83.00K	$336.0K
YoY Change	-21.43%	-75.3%	8300.0%
Acquisitions
YoY Change
Other Investing Activities	$1.143M	$1.636M	-$6.988M
YoY Change	65.65%	-123.41%	-1162.01%
Cash From Investing Activities	$1.088M	$1.553M	-$7.324M
YoY Change	78.36%	-121.2%	-1206.34%
FINANCING ACTIVITIES
Cash Dividend Paid		$14.49M	$28.98M
YoY Change		-50.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.000K	-14.49M	-29.20M
YoY Change	-101.36%	-50.38%	-3853.6%
NET CHANGE
Cash From Operating Activities	-1.853M	-3.155M	-7.401M
Cash From Investing Activities	1.088M	1.553M	-7.324M
Cash From Financing Activities	3.000K	-14.49M	-29.20M
Net Change In Cash	-762.0K	-16.09M	-43.93M
YoY Change	-45.18%	-63.37%	20918.18%
FREE CASH FLOW
Cash From Operating Activities	-$1.853M	-$3.155M	-$7.401M
Capital Expenditures	$55.00K	$83.00K	$336.0K
Free Cash Flow	-$1.908M	-$3.238M	-$7.737M
YoY Change	3.14%	-58.15%	368.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2820000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955802	shares
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30796000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	25552000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11628000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	845000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	129000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1851000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-204000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	990000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	530000	usd
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	CLEARONE INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000840715
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33660
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0398877
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5225 Wiley Post Way, Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84116
	dei	City Area Code CityAreaCode	(801)
	dei	Local Phone Number LocalPhoneNumber	975-7200
	dei	Security12b Title Security12bTitle	Common Stock, $0.001
	dei	Trading Symbol TradingSymbol	CLRO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23969148	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2450000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17835000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1852000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3480000	usd
CY2024Q2	clro	Receivables Legal Settlement ReceivablesLegalSettlement	0	usd
CY2023Q4	clro	Receivables Legal Settlement ReceivablesLegalSettlement	4000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2574000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3279000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	14599000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	10625000	usd
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	27000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	36000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3855000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4062000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	25357000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	43317000	usd
CY2024Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	621000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	916000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	1772000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3143000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	552000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	804000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	990000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1582000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1689000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	108000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	109000	usd
CY2024Q2	us-gaap	Assets Assets	30796000	usd
CY2023Q4	us-gaap	Assets Assets	50694000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1901000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1945000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1726000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2290000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3650000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4265000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	515000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	665000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1079000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1079000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	5244000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6009000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23969148	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23969148	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23969148	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23969148	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31616000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	46047000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-294000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-310000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5794000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1076000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	44685000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50694000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2304000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5483000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5926000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9661000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2324000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3635000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4795000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6498000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-20000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1848000	usd
	us-gaap	Gross Profit GrossProfit	1131000	usd
	us-gaap	Gross Profit GrossProfit	3163000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1191000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2503000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2515000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	868000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	873000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1762000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1916000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1007000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1868000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2276000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2904000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3203000	usd
	us-gaap	Operating Expenses OperatingExpenses	6133000	usd
	us-gaap	Operating Expenses OperatingExpenses	6707000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2924000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1355000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5002000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3544000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	91000	usd
	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	383000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	119000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	437000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	297000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2103000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2805000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1009000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4705000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1824000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4718000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1851000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23969148	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23969148	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955785	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23969148	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955802	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23969148	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955785	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2820000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1019000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4718000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	19000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2824000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1006000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4702000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1833000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4718000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1851000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	273000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	449000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	186000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	217000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	52000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	47000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	98000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	103000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	71000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-4705000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	629000	usd
	clro	Increase Decrease In Legal Settlement Receivables IncreaseDecreaseInLegalSettlementReceivables	0	usd
	clro	Increase Decrease In Legal Settlement Receivables IncreaseDecreaseInLegalSettlementReceivables	-55000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2701000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-657000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-206000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3536000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-43000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1151000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-511000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	9000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-5310000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-11000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-200000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-235000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2722000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	52920000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	135000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	326000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	53000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	79000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5372000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2344000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3358000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9332000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1826000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7393000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	14490000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	28979000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2450000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14483000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31428000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15385000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14102000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17835000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	984000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2450000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15086000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6631000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	273000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2450000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17835000	usd
CY2024Q2	clro	Working Capital Deficit WorkingCapitalDeficit	21707000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2722000	usd
	clro	Increase Decrease In Net Cash Provided By Used In Operating Activities IncreaseDecreaseInNetCashProvidedByUsedInOperatingActivities	55642000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	52920000	usd
CY2024Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	14490000	usd
CY2023Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	28979000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2304000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5483000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5926000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9661000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2304000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5483000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5926000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9661000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2820000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1019000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4718000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1851000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23969148	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955802	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23969148	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955785	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23969148	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955802	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23969148	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955785	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q2	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6420553	shares
CY2023Q2	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6287019	shares
	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6420553	shares
	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6327495	shares
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6420553	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6287019	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6420553	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6327495	shares
CY2024Q2	clro	Available For Sale Marketable Securities Amortized Cost AvailableForSaleMarketableSecuritiesAmortizedCost	2468000	usd
CY2024Q2	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Gain AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain	6000	usd
CY2024Q2	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Loss AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss	1000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	2473000	usd
CY2023Q4	clro	Available For Sale Marketable Securities Amortized Cost AvailableForSaleMarketableSecuritiesAmortizedCost	4412000	usd
CY2023Q4	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Gain AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain	7000	usd
CY2023Q4	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Loss AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss	23000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	4396000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1847000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1852000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	622000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	621000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	0	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	0	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2469000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2473000	usd
CY2024Q2	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairValue	2473000	usd
CY2024Q2	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	-1000	usd
CY2024Q2	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairValue	0	usd
CY2024Q2	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2024Q2	clro	Marketable Securities Available For Sale Unrealized Loss Position Fair Value MarketableSecuritiesAvailableForSaleUnrealizedLossPositionFairValue	2473000	usd
CY2024Q2	clro	Marketable Securities Available For Sale Unrealized Loss Position Accumulated Loss MarketableSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	-1000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairValue	4396000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	-23000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairValue	0	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2023Q4	clro	Marketable Securities Available For Sale Unrealized Loss Position Fair Value MarketableSecuritiesAvailableForSaleUnrealizedLossPositionFairValue	4396000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Unrealized Loss Position Accumulated Loss MarketableSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	-23000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11099000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11047000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9517000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9358000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1582000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1689000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	160000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	247000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	99000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	198000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	68000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	23000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	996000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1582000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2971000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2086000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8539000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	14599000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	10625000	usd
CY2024Q2	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	997000	usd
CY2023Q4	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	1789000	usd
CY2024Q2	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	775000	usd
CY2023Q4	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	1354000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	1772000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3143000	usd
CY2024Q2	us-gaap	Inventory Write Down InventoryWriteDown	-95000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	80000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	98000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	103000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	118000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	110000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	227000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	259000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	232000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	264000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	341000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	804000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	333000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	383000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	515000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	665000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	848000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1048000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M17D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M20D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0659	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0647	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	208000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	272000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	210000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	216000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	37000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	943000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	95000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	848000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	25552000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	43366000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	25552000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	43366000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	607810	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.03
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	107500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	480310	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.52
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	97000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y2M15D
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	47000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1079000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	2473000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	4396000	usd

Files In Submission

Name	View Source	Status
0001753926-24-001441-index-headers.html	Edgar Link	pending
0001753926-24-001441-index.html	Edgar Link	pending
0001753926-24-001441.txt	Edgar Link	pending
0001753926-24-001441-xbrl.zip	Edgar Link	pending
clro-20240630.htm	Edgar Link	pending
clro-20240630.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
clro-20240630_def.xml	Edgar Link	unprocessable
clro-20240630_lab.xml	Edgar Link	unprocessable
clro-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
clro-20240630_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clro-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRO
CLEARONE INC Stock $clro

2024 Q3 Form 10-Q Financial Statement

#000175392624001441 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO CLEARONE INC Stock $clro

2024 Q3 Form 10-Q Financial Statement

#000175392624001441 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO
CLEARONE INC Stock $clro